GGrantIndex
Sort

53,477 grants matching addiction

Sex Differences and Progesterone Effects on Impulsivity, Smoking & Cocaine Abuse

$525,000
Marilyn E. Carroll · University Of Minnesota · P50 · FY2017 · DA

Impact of maternal marijuana use on epigenetic regulation of offspring neurodevelopment

$525,000
Jamie Lo · Oregon Health & Science University · DP1 · FY2024 · DA

Impact of maternal marijuana use on epigenetic regulation of offspring neurodevelopment

$525,000
Jamie Lo · Oregon Health & Science University · DP1 · FY2025 · DA

Impact of maternal marijuana use on epigenetic regulation of offspring neurodevelopment

$525,000
Jamie Lo · Oregon Health & Science University · DP1 · FY2022 · DA

1) EXERCISE ADDITIONAL "UP-TO HOURS" DURING OPTION YEAR TWO (2)2) REVISE ATTACHMENT 2: OTHER TERMS AND CONDITIONS, P.4, HHSAR 352.237-75 KEY PERSONNEL TO SUPPORT THE NIMH NDA WHICH IS A SINGLE DATA

$524,995
Timothy Smith · · N02 · FY2023 · DA

Role of prefrontostriatal circuits in effort-based, cost-benefit decision making

$524,943
Scott Allen Wilke · University Of California Los Angeles · R01 · FY2024 · MH

Genetics of RNA Tumor Viruses

$524,891
G Steven Martin · University Of California Berkeley · R37 · FY2009 · CA

Novel Pharmacotherapy for Dual Dependence

$524,890
University Of Virginia Charlottesville · R01 · FY2005 · DA

Intervention to Promote Healthy Behaviors in Homeless Youth

$524,882
Donna Lynn Rew · University Of Texas At Austin · R01 · FY2017 · HD

Psychosocial and neurobiological stress and opioid use trajectories following pregnancy

$524,863
Helena Jv Rutherford · Yale University · R01 · FY2024 · DA

Development of NMUR2 Antagonists as Novel Analgesics

$524,835
Neil Cutshall · Omeros Corporation · R44 · FY2012 · DA

Intranet-based Tobacco Prevention Program for Children

$524,745
Oregon Research Institute · R01 · FY2004 · CA

Naltrexone for the treatment of Actively-Using Met-Dependent MSM with High-Risk B

$524,718
Phillip O Coffin · Public Health Foundation Enterprises · R01 · FY2015 · DA

EpiCenter ? EPIdemiology of opioid prescribing in community health CENTERs

$524,707
John Muench · Oregon Health & Science University · R01 · FY2018 · DA

Reprogramming KZFP function to understand drug-specific transcription and behavior

$524,682
Peter James Hamilton · Virginia Commonwealth University · R01 · FY2025 · DA

Reduction of opioid requirement associated with Auriculo-nerve stimulation following open surgery

$524,560
Jacques E. Chelly · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DA

Translational Studies on Early-life Stress and Vulnerability to Alcohol Addiction

$524,518
Jeffrey L. Weiner · Wake Forest University Health Sciences · P01 · FY2013 · AA

Early Exposure to Stimulants as a Risk Factor for Substance Abuse

$524,495
Linda J. Porrino · Wake Forest University Health Sciences · R01 · FY2009 · DA

Training Program: Drugs of Abuse & Related Neuropeptides

$524,471
Ellen M Unterwald · Temple Univ Of The Commonwealth · T32 · FY2019 · DA

Small G proteins and alcohol use disorder

$524,336
Dorit Ron · University Of California, San Francisco · R01 · FY2020 · AA

Stress, Arousal and Mood: Affective Influences on Decisions under Uncertainty

$524,324
Elizabeth A. Phelps · Harvard University · R01 · FY2020 · DA

Marketing Monitoring Core (MMC)

$524,321
Ce Shang · Ohio State University · U54 · FY2025 · CA

Jail-Based Treatment to Reduce Substance Abuse, Recidivism and Risky Behavior

$524,281
June P Tangney · George Mason University · R01 · FY2015 · DA

Neural dynamics of human working memory networks

$524,227
Mark D'esposito · University Of California Berkeley · R01 · FY2019 · MH

Neural dynamics of human working memory networks

$524,227
Mark D'esposito · University Of California Berkeley · R01 · FY2018 · MH